Regulations.gov document
Acknowledgement Letter from FDA DMS to Hyman, Phelps & McNamara, P.C. on behalf of United…
Other · FDA-2024-P-2326 · posted May 14, 2024
Key facts
| Document ID | FDA-2024-P-2326-0002 |
|---|---|
| Title | Acknowledgement Letter from FDA DMS to Hyman, Phelps & McNamara, P.C. on behalf of United Therapeutics Corporation |
| Document type | Other |
| Subtype | Acknowledgement Letter/Receipt |
| Agency | FDA |
| Docket | FDA-2024-P-2326 |
| Posted | May 14, 2024 |
| Comment period opens | May 14, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: